drugset / Trial / NCT06122012
To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China
RandomizedParallel-groupOpen-labelTreatment
Summary
Observe the effects of HSK16149 capsule combined with acetyl-L-carnitine hydrochloride tablets and lipoic acid combined with acetyl-L-carnitine hydrochloride tablets Efficacy and safety in diabetic peripheral neuralgia patients in China
Timeline
- Start
- 2023-05-01
- Primary completion
- 2024-04-30
- Completion
- 2024-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK16149 | Unknown | 20 mg | Oral |
| Subject | alpha-lipoic acid | Small molecule | 0.6 g | Oral |
| Background | L-carnitine | Other / unclassified | 0.5 g | Oral |